UBS Group
EDVA

UBS Group’s Endovia Health Sciences, Inc. EDVA Stock Holding History

UBS Group’s Portfolio EDVA Stock Details EDVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-13,278
Closed -$19.1K – 10957
2026
Q1 		$19.1K Buy
13,278
+9,504
+252% +$22K ﹤0.01% 7975
2025
Q4 		$10.4K Buy
3,774
+3,771
+125,700% +$22.6K ﹤0.01% 8221
2025
Q3 		$24 Sell
3
-520
-99% -$4.53K ﹤0.01% 10117
2025
Q2 		$7.87K Buy
+523
New +$8.56K ﹤0.01% 8996
2025
Q1 		– Sell
-1,578
Closed -$40.7K – 10658
2024
Q4 		$40.7K Buy
1,578
+535
+51% +$17.7K ﹤0.01% 7428
2024
Q3 		$42.1K Buy
+1,043
New +$52.5K ﹤0.01% 6926
2024
Q1 		– Sell
-18
Closed -$1.6K – 9929
2023
Q4 		$1.6K Buy
+18
New +$1.71K ﹤0.01% 8266
2023
Q3 		– Sell
-6
Closed -$1.01K – 9895
2023
Q2 		$1.01K Sell
6
-32
-84% -$5.85K ﹤0.01% 8039
2023
Q1 		$10.1K Sell
38
-12
-24% -$2.38K ﹤0.01% 7611
2022
Q4 		$7.69K Buy
50
+45
+900% +$7.89K ﹤0.01% 8870
2022
Q3 		$1K Buy
5
+4
+400% +$1.52K ﹤0.01% 10022
2022
Q2 		$0 Hold
1
– – ﹤0.01% 10854
2022
Q1 		$0 Sell
1
-69
-99% -$35.2K ﹤0.01% 10815
2021
Q4 		$13K Buy
70
+56
+400% +$15.1K ﹤0.01% 8471
2021
Q3 		$4K Sell
14
-17
-55% -$7.68K ﹤0.01% 8673
2021
Q2 		$18K Buy
+31
New +$17K ﹤0.01% 7454

Other funds holding EDVA

Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
PM
Phraction Management Colchester, Connecticut $596M AUM 36.77% 1-Year Est. Return
STA
Summit Trail Advisors New York $7.95B AUM 26.49% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
LWM
Lifetime Wealth Management Rockwall, Texas $171M AUM
CFM
Compass Financial Management Tampa, Florida $829M AUM
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

UBS Group's EDVA Position: Q2 2026 in Review

UBS Group sold out of Endovia Health Sciences, Inc. (EDVA) in Q2 2026, closing a stake of 13,278 shares — an estimated $19.1K sold.

UBS Group first reported a position in EDVA in Q2 2021 and held it in 16 quarters. The position peaked at $42.1K in Q3 2024. 18 funds tracked by Wall St. Rank hold EDVA as of Q2 2026.

  • UBS Group reported no remaining Endovia Health Sciences, Inc. position as of Q2 2026 after selling out during the quarter.
  • UBS Group sold 13,278 Endovia Health Sciences, Inc. shares in Q2 2026, an estimated $19.1K.
  • UBS Group first reported a position in Endovia Health Sciences, Inc. in Q2 2021 and held it in 16 quarters.
  • UBS Group's Endovia Health Sciences, Inc. position peaked at $42.1K in Q3 2024.
  • 18 funds tracked by Wall St. Rank held Endovia Health Sciences, Inc. as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.